Zal RFK alle vaccingoedkeuringen beëindigen tegen 31 december?
Ja
$7,093 Vol.
$7,093 Vol.
Dec 31, 2025
Regels
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Gemaakt op: Sep 3, 2025, 11:16 PM ET
Volume
$7,093Einddatum
Dec 31, 2025Gemaakt op
Sep 3, 2025, 11:16 PM ETResolver
0x65070BE91...Resultaat voorgesteld: Nee
Geen bezwaar
Definitief resultaat: Nee
Zal RFK alle vaccingoedkeuringen beëindigen tegen 31 december?
Ja
$7,093 Vol.
$7,093 Vol.
Dec 31, 2025
Over
This market will resolve to "Yes" if any vaccine has its Biologics License Application (BLA) approval or Emergency Use Authorization (EUA) revoked by the FDA or is voluntarily withdrawn for reasons related to health, safety, or efficacy by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Withdrawing approval solely due to seasonality, low demand, or an emergency ending will not be sufficient for a "Yes" resolution. Similarly, a reduction in the scope of approved recipients, without fully eliminating the approval will not be sufficient for a "Yes" resolution."
The resolution source will be official FDA announcements and guidance published on the FDA website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$7,093Einddatum
Dec 31, 2025Gemaakt op
Sep 3, 2025, 11:16 PM ETResolver
0x65070BE91...Resultaat voorgesteld: Nee
Geen bezwaar
Definitief resultaat: Nee
Pas op voor externe links.
Pas op voor externe links.

Pas op voor externe links.
Pas op voor externe links.